Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-21-000498
Filing Date
2021-01-25
Accepted
2021-01-25 09:41:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 LANTERN PHARMA INC. p21-0211sc13g.htm SC 13G 78516
  Complete submission text file 0000902664-21-000498.txt   80095
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020 212-608-3300
Empery Asset Management, LP (Filed by) CIK: 0001469336 (see all company filings)

EIN.: 262107121 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Subject) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91536 | Film No.: 21548225
SIC: 2834 Pharmaceutical Preparations